Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> DIABETES Latest News

JAN 08, 2013 - MedPage Today

A Must Read - Share

FDA Staff Flag Renal Risk of Diabetes Drug

(MedPage Today) -- The novel type 2 diabetes drug canagliflozin (Invocana) is effective at lowering blood glucose, but FDA reviewers have raised concerns about renal and fracture risks.

Tags: FDA Staff Flag Renal Risk of Diabetes Drug,  Diabetes Latest News